Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  Tekcapital plc    TEK   GB00BKXGY798

TEKCAPITAL PLC

(TEK)
  Report
Delayed Quote. Delayed London Stock Exchange - 10/21 05:39:06 am
10.15 GBX   -7.73%
10/01TEKCAPITAL : Option Exercise
PU
09/28PORTFOLIO COMPANY UPDATE : Lucyd
PU
09/24PORTFOLIO COMPANY UPDATE : Salarius
PU
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensus 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

Tekcapital : Unaudited Interim Results

share with twitter share with LinkedIn share with facebook
08/21/2020 | 12:21am EDT

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). With the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

21 August 2020

Tekcapital plc

("Tekcapital", "the Company" or "the Group")

Unaudited Half-Yearly Report for the period ending 31 May 2020

Continued Progress with Portfolio Companies & Record Net Assets

Tekcapital plc (AIM: TEK) a UK intellectual property (IP) investment group focused on creating marketplace value from investing and commercializing university technology announces its results for the six-month period ended 31 May 2020.

Financial highlights

  • Net Assets increased 16% to US$26.18m (30 Nov 2019: US$22.53m)
  • NAV per share US$0.30 (30 Nov 2019: US$0.35)
  • Total Revenue of US$2,859,647 (H1 2019: US$5,401,568)
    o Net increase of US$2,422,949 in fair value of portfolio companies
  • Revenue from services US$557,684 (H1 2019: $614,394)
  • Reduction of operating expenses by 4% to US$711,300 (H1 2019: US$740,947).
    o Service revenue cover appx. 58% of current cost base (H1 2019: 63%)
  • Profit before tax of US$1,897,629 (H1 2019: US$4,421,279)
  • Placements of 14,800,000 new ordinary shares of 0.4 pence each in the Company ("new ordinary shares") to raise gross proceeds of US$962,000 in February 2020 and 9,250,000 new ordinary shares to raise gross proceeds of US$1,115,000 in May 2020.

Operational highlights: Portfolio Companies

Salarius® (91.7% ownership) www.salarius.co

  • On 12 December 2019, Salarius Ltd secured a national food ingredient broker for Microsalt®. Accurate Ingredients provides network of experienced sales representatives on the east and west coast of the United States.
  • On 24 January 2020, Salarius Ltd secured an additional food ingredient broker partner for sales of Microsalt®. The agreement with Hanks Brokerage Inc. covers primarily snack food companies in the southwestern United States
  • On 2 March 2020, Salarius Ltd announced a North American distribution agreement for launch of SaltMe!®snacks. This agreement with UNFIrepresents an important milestone for Salarius' new potato chip snack line, enabling unprecedented reach of SaltMe!® products into consumer outlets of every size in North America.
  • On 4 March 2020, SaltMe!® announced sales partnership agreement with iLevel Brands Inc.as part of its launch of North America sales of its full-flavour-low sodium potato chips. This agreement, combined with their previously announced distribution agreement on 2 March 2020, will expand SaltMe!® market penetration and brand awareness for its products with retail brand placements across the entire East Coast, Midwest and Southwest geographic areas of the United States.
  • On 24 March 2020, Salarius Ltd announced it had received an order from its distribution partner to launch sales of its new SaltMe!® full flavor-low sodium snacks in 71 stores beginning in May 2020.

Lucyd® (100% ownership) www.lucyd.co

  • On 26 March 2020, Lucyd Ltd announced it had filed patent and trademark on its forthcoming VyrbTM app. Vyrb users will be able to listen and produce social media posts with their voice, without having to look at their smartphones or type messages. The app is designed to improve utility of Lucyd Bluetooth® glasses and other wireless hearables like AirPods®
  • On 24 April 2020, Lucyd Ltd announced the launch of its Bluetooth® enabled glasses on the website of US superstore Walmart.com.

Guident (100% ownership) www.guident.co

  • On 8 April 2020, Guident Ltd announced significant management additions including appointment of
    Harald Braun as Company's CEO and appointment of Daniel Grossman as the company's Chief
    Revenue Officer. The company also appointed Michael Trank as VP Software Development and Dr. Gabriel Castenada as Lead Architect, Artificial Intelligence Software. Guident has also announced that it has received a Notice of Allowance from the United States Patent and Trademark Office for its U.S. patent # 10,699,580 entitled "Methods and Systems for Emergency Handoff of an Autonomous Vehicle" and has filed an additional patent entitled, "Intelligent Remote Monitoring and Control of Autonomous Vehicles". These patent teach new methods to improve the safety of autonomous vehicles and land-based delivery drones.
  • On 22 May 2020, Guident Ltd announced it had won the Florida Atlantic University (FAU) competition as one of the most promising startups in South Florida, defeating over 200 contestants. The judges were convinced that the company creating a Remote Monitoring and Control Center in Florida for autonomous vehicles applying artificial intelligence, and their first use-case for 'zero- touch' ground-based delivery of groceries and medicines, would be the right choice to create significant value in South Florida and Nationwide.

Belluscura® (18% ownership) www.belluscura.com

  • Continued progress with its unique and patented portable oxygen concentrator (POC) programme and is anticipating FDA 510K clearance in H2 2020.
  • On 10 February 2020, Belluscura filed an additional patent application (17 patents filed or licensed to-date) entitled "Improved Extracorporeal Membrane Oxygenation Device, System and Related Methods," covering devices and systems for treating people suffering from acute respiratory distress caused by the Coronavirus.

Operational highlights: Corporate

As part of continuing to expand our services in Latin America:

  • Tekcapital delivered a webinar on commercialising university IP with the Creativity and Innovation Center 4.0 of the Universidad Tecnológica de Querétaro. This resulted in the formation of a strategic alliance with Universidad Tecnológica de Querétaro for providing Tekcapital's services in Mexico.
  • Tekcapital was invited to the Petrobras facilities to present new global opportunities and collaborations in the context of intellectual property licensing.
  • Executed a strategic alliance agreement with LicenciArte Colombia, a consultancy firm that offers services for institutional strengthening, protection and commercialization of technologies from universities and research labs
  • Delivered a successful webinar in Brazil titled "Agritech Startups", which gathered more than 60 key players from the Brazilian technology and innovations ecosystem.

Post period end highlights:

  • On 16 June 2020, Guident Ltd announced appointments of Professor Naphtali Rishe, Professor Hayder Radha and Dr. Marielle S. Gross to its Science Advisory Board
  • On 17 June 2020, Belluscura plc announced it is making good progress with its 510K submission though it has been impacted by COVID-19 associated external supply chain issues which has increased the scarcity of certain key components, increased lead times, and reduced capacity at part

manufacturers and testing facilities. Belluscura is in the process of completing the final surety tests and anticipates it will receive 510K clearance within H2 2020.

  • On 1 July 2020, Innovative Eyewear, Inc, a new, fully owned subsidiary of Lucyd Ltd, commenced its Regulation Crowdfunding program on StartEngine, where it is seeking to raise approximately US $400K at a $3.75m pre-money valuation. The purpose of the fundraise is to provide additional capital for the further development and launch of its new Lucyd Lyte™ smart glasses and Vyrb™ voice controlled, social media app.
  • On 13 July, 2020 Lucyd Ltd received Notice of Allowance from the United States Patent and Trademark Office for 13 of its previously filed smart glass design patents.
  • On 22 July, 2020, Lucyd Ltd filed two design patents on their upcoming Lucyd Lyte™ smart glasses.
  • On 27 July 2020, Tekcapital announced that Mr. Malcolm Groat has stepped down from the Board of Directors at the end of his term with immediate effect. Konrad Dabrowski, who for the past three years has served as the Group's Financial Controller, has been promoted to non-board CFO.

Dr. Clifford M. Gross, Chairman said: 'We are pleased to report a successful half-year performance for the Group, which has noted record net assets for the period and the achievement of important development milestones for most of its portfolio companies. We believe our approach of acquiring and commercialising university innovations is demonstrating good progress towards our goal of improving the quality of life for customers whilst delivering significant returns on invested capital.'

For further information, please contact:

Tekcapital Plc

Via Flagstaff

Clifford M. Gross, Ph.D.

SP Angel Corporate Finance LLP

+44 (0) 20 3470 0470

(Nominated Adviser and Broker)

Richard Morrison/Charlie Bouverat (Corporate Finance)

Abigail Wayne / Rob Rees (Corporate Broking)

Flagstaff Strategic and Investor Communications

+44 (0) 20 7129 1474

Tim Thompson/Andrea Seymour/Fergus Mellon

About Tekcapital plc

Tekcapital creates value from investing in new, university-developed intellectual properties and provides a range of IP investment services to make it easy for organisations to commercialise university-developed technology. Tekcapital is quoted on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in Oxford, in the UK. For more information, please visit www.tekcapital.com

LEI: 213800GOJTOV19FIFZ85

Risk Factors and Forward-Looking Statements

The information contained in this document has been prepared and distributed by the Company and is subject to material updating, completion, revision, verification and further amendment. This Report is directed only at Relevant Persons and must not be acted on or relied upon by persons who are not Relevant Persons. Any other person who receives this Report should not rely or act upon it. By accepting this Report the recipient is deemed to represent and warrant that: (i) they are a person who falls within the above description of persons entitled to receive the Report; (ii) they have read, agree and will comply with the contents of this notice. The securities mentioned herein have not been and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or under any U.S. State securities laws, and may not be offered or sold in the United States of America or its territories or possessions (the "United States") unless they are registered under the Securities Act or pursuant to an exemption from or in a transaction not subject to the registration requirements of the Securities Act. Neither this Report nor any

copy of it may be taken or transmitted into the United States, or distributed, directly or indirectly, in the United States, or to any "US person" as defined in Regulation S under the Securities Act of 1933, including US resident corporations or other entities organised under the laws of the United States or any state thereof or non-U.S. branches or agencies of such corporations or entities. This Report is not being made available to persons in Australia, Canada, Japan, the Republic of Ireland, the Republic of South Africa or any other jurisdiction in which it may be unlawful to do so and it should not be delivered or distributed, directly or indirectly, into or within any such jurisdictions.

All statements of opinion and/or belief contained in this Report and all views expressed represent the directors' own current assessment and interpretation of information available to them as at the date of this Report. In addition, this Report contains certain "forward-looking statements", including but not limited to, the statements regarding the Company's overall objectives and strategic plans, timetables and capital expenditures. Forward-looking statements express, as at the date of this Report, the Company's plans, estimates, valuations, forecasts, projections, opinions, expectations or beliefs as to future events, results or performance. Forward-looking statements involve a number of risks and uncertainties, many of which are beyond the Company's control, including those associated with COVID-19, and there can be no assurance that such statements will prove to be accurate. No assurance is given that such forward looking statements or views are correct or that the objectives of the Company will be achieved. Further, valuations of Company's portfolio investments and net asset value can and will fluctuate over time due to a variety of factors. The Company does not undertake to update any forward-looking statement or other information that is contained in this Report.

Chairman's statement

Tekcapital brings innovations from lab to market. In the first half of 2020, many of our key portfolio companies have made significant progress and as a result, our net assets ended the period at record levels.

Key portfolio companies

Tekcapital Plc commercialises university intellectual property, a process known as technology transfer, both for its own portfolio and as a service for client companies.

Over the past four years we have built a compelling group of diversified portfolio companies to commercialize high value properties we have uncovered. We believe that when you couple commercialization ready, compelling university IP with strong senior management, you increase the probability that vibrant companies will emerge, net assets will grow, returns on invested capital are likely to increase and exits should occur faster. When we realise exits, the Group's goal is to distribute the portion of proceeds as a special dividend to our shareholders.

The Company believes that there is considerable value to be realised from its portfolio companies and is continuing to further assist and invest in these operations. A common theme across our portfolio companies is that they have proprietary intellectual property, capable management and if successful, will improve the quality of life for the customers they serve. The Company's portfolio of key investments includes:

  • Salarius ltd (www.salarius.co), of which Tekcapital owns 91.7%, owns a patented process for producing nano-particle sized salt crystals ("MicroSalt®"), which can reduce sodium consumption in snack foods by up to 50.0%, yet provide the same level of salty flavour found in traditional snacks. Salarius' goal is to make snack foods healthier. According to the World Health Organization, cardiovascular disease takes the lives of 17.9 million people per year and is responsible for 31% of global deaths and as such the low sodium ingredient market is estimated to reach US$1.76 billion by 20251.
  • Lucyd ltd (www.lucyd.co), which is wholly owned by Tekcapital, sells innovative Bluetooth enabled glasses, regular spectacles and owns 13 design patents and two utility patent applications for its Bluetooth® enabled sound glasses. We believe Lucyd is the first company to offer proper prescription glasses online that allow the wearer to connect to their smartphones and digital assistants. Their mission is to Upgrade your Eyewear® with useful hands-free technology. 2019 witnessed the largest number of pedestrian injuries in the last 30 years2 and every seven minutes a pedestrian is struck by a car due primarily to both drivers and pedestrian alike being distracted with their smart phones. Lucyd's glasses have speakers built into the arms of the glasses which allows users to make calls and listen to music, whilst maintaining situational awareness of the traffic around them having nothing placed in the ears. Additionally, Lucyd is developing a voice controlled app called Vyrb™ which will allow eyeglass wearers to respond to posts on Facebook and Twitter with their voice, obviating the need to look at their phones or type responses. Lucyd is positioned at the intersection of the online eyewear and digital assistant markets. Online eyewear sales in the U.K. are projected to reach $824m3 in 2019. The U.S. online eyewear market is projected to reach US$3.5bn in 2019 and expected to grow annually by 1.3%4.
  • Guident, ltd (www.guident.co), which is wholly owned by Tekcapital, was established to commercialise new technology to enhance the utility, safety and enjoyment of autonomous vehicles ("AVs") and drones. Using its proprietary IP, Guident seeks to develop software Apps and IP that allow users of AV's and drones to dispatch their vehicles to join ridesharing fleets, find available parking spots and charging stations and report and respond to accidents as well as provide remote, tele-monitoring and control for AV's and land-based delivery drones. Remote monitoring and control is a legal requirement for AV operation in
  1. https://www.futuremarketinsights.com/reports/sodium-reduction-ingredient-market
  2. https://www.caranddriver.com/news/a31136893/pedestrian-deaths-increase-2019/
  3. https://www.statista.com/outlook/12000000/156/eyewear/united-kingdom
  4. https://www.statista.com/statistics/428692/projected-size-of-global-autonomous-vehicle-market-by-vehicle-type/

the State of Florida and other jurisdictions. The autonomous vehicle market is expected to reach US $65.3 billion by 20275.

  • Belluscura plc (www.belluscura.com), of which Tekcapital now owns approximately 18%, has developed an improved portable oxygen concentrator (POC) to provide on-the-go supplemental O2. They have continued to report progress in their advanced POC program, which they believe will be smaller, lighter and quieter then competitive products and will have a replaceable filter cartridge that will allow the user to upgrade the unit as their disease progresses. As a result of the global prevalence of COPD, the medical portable oxygen market is expected to grow from $1.4bn in 2018 to $2.4bn by 20246. A recent report by Grand View Researchindicates an increasing demand for portable oxygen concentrators, and anticipates unit sales to grow from 405k units per year in 2019 to 581k units per year in 2026 for a total value of $1.4bn. This anticipated growth may have a positive impact on portfolio company Belluscura.

Corporate

In H1 2020 we continued with the expansion of our consulting services into Latin America. Whilst service revenues were modestly reduced for the period, they still covered approximately 58% of our administrative expenses. This was made possible with the steadfast control of administrative and marketing expenses coupled with the judicious use of consultants to minimize fixed costs.

During the period, we have enhanced the Board with the appointments of Louis Castro who is Chair of our audit committee and also serves on our remuneration committee and Lord David Willetts who also serves on the nomination committee.

Louis is highly experienced director and chartered accountant with thirty years experience in industry and in financial services, including positions as Chief Executive, Finance Director and Non-Executive Director of several AIM listed companies. He was previously the CFO at Eland Oil & Gas plc where he had full executive responsibility for finance, legal, corporate finance and a budget of over $150m. Louis currently serves as a non-executive director of Stanley Gibbons Group plc, Predator Oil & Gas Holdings plc and Orosur Mining Inc. Louis is a Fellow of the Institute of Chartered Accountants of England & Wales.

The Rt Hon Lord Willetts, FRS, is President of the Resolution Foundation and former U.K. Minister for Universities and Science. He served as the Member of Parliament for Havant (1992-2015), and previously worked at HM Treasury and the No. 10 Policy Unit. Lord Willetts is a visiting Professor at King's College London, former Chair of the British Science Association and a member of the Council of the Institute for Fiscal Studies. He is also an Honorary Fellow of Nuffield College, Oxford. Lord Willetts is a graduate of Oxford University and has been awarded numerous honorary doctorates.

Post end of period we are glad to announce that Konrad Dabrowski has been promoted to CFO. Konrad has served as Group Financial Controller for Tekcapital over the past three years. He has extensive experience in accounting and finance obtained through more than a decade of exposure to public accounting and the private sector. He began his career with Deloitte and continued as an audit manager in the Deloitte Washington, DC office. Konrad also held the global accounting manager role in Restaurant Brands International (NYSE:QSR). Konrad is a CPA and holds a Master of Science degree in finance and accounting from the Warsaw School of Economics. Konrad replaces Malcolm Groat our Finance Director, to whom we are thankful for six years of dedicated service to the Company.

In addition, post end of period we are pleased to announce the promotion Mellissa Cruz to Director of Client Services. Melissa helps our global university and corporate clients create marketplace value from IP. She has collaborated with a diverse set of organizations in Latin America and Europe, to facilitate the evaluation and transfer of university discoveries to the marketplace. Melissa has a marketing and sales background with companies such as Newmark Grubb Caribbean and has contributed significantly to Tekcapital's development of new business in Latam countries. She received her B.A. in International Business and an M.S. in Marketing

  1. https://www.statista.com/statistics/428692/projected-size-of-global-autonomous-vehicle-market-by-vehicle-type/
  2. Global Market Insights: Oxygen Cylinders Market Size and Competitive Market Share & Forecast, 2017 -2024

from Florida International University and is fluent in Spanish and English. Melissa replaces Amy Shim to whom we are also thankful for six years of dedicated service.

Financial performance

In spite of the significant headwinds resulting from COVID-19 and an economic recession in the U.K. and the U.S, H1 2020 saw another period for continued value creation for the Group as evidenced by a 16% increase in net assets. The Group was able to accomplish this whilst simultaneously reducing administrative costs by 4%. The Group has now demonstrated 3.5 years of consistent growth of Net Assets. Due to the quickening pace of innovation, patented, exogenously developed university technologies are a valuable currency, and as a result, we are bullish on the market opportunity for the Group which we believe will continue to grow apace in lock-step with the progress of our portfolio companies.

Fundraisings

On 6 February 2020, the Group announced that it had completed a fundraising of US$0.96 million gross through the placing of 14,800,000 new Ordinary Shares with new and existing investors at a price of 5 pence per new Ordinary Share. On 1 May 2020, the Group announced it had completed a second fundraising of US$1.15m through placing of 9,250,000 new Ordinary Shares with new and existing investors at a price of 10 pence per new Ordinary Share. The new funds are being utilized for accelerating portfolio company growth and for working capital.

Current Trading and Outlook

Having continued to develop and expand Tekcapital's existing business, the Board is confident that continued investment in our portfolio companies remains the right approach for long-term value creation. Additionally, we are currently exploring external, early-stage funding for a number of our portfolio companies. Further, we believe that we are executing on our strategy and this should result in further increases in returns on invested capital as our portfolio companies continue to mature towards meaningful inflection points and exits.

Whilst it is clear that the Company is progressing very well, net asset values will fluctuate from period to period due to individual portfolio company performance, valuations and changes in market conditions and macro-economic financial conditions including the recent Coronavirus epidemic. We are grateful for the patience and support of our shareholders. We are also sincerely appreciative of our dedicated, creative and incredibly hardworking team without which, none of the results reported herein would be possible. In particular I would like to thank our portfolio company leadership including Robert Rauker (Belluscura), Harald Braun (Guident), Victor Manzanilla (Salarius) and Harrison Gross (Lucyd) who collectively have punched above their weight and as a result their businesses are rapidly approaching material inflection points.

Dr Clifford M Gross

Chairman and CEO

21 August 2020

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

For the six months ended 31 May 2020

Notes

Six months ended

Six months ended 31

Year ended 30

31 May 2020

May 2019

November

2019

Unaudited

Unaudited

Audited

US$

US$

US$

Continuing Operations

Revenue from services

557,684

614,394

1,200,551

Unrealised profit on the revaluation of

7

2,301,963

4,787,174

6,516,813

investments

Total Revenue

2,859,647

5,401,568

7,717,364

Cost of sales

(248,900)

(239,342)

(606,166)

Gross Profit

2,610,747

5,162,226

7,111,198

Administrative expenses

(711,300)

(740,947)

(1,590,563)

Operating Profit

1,899,447

4,421,279

5,520,635

Profit on ordinary activities before income

tax

Income tax expense

(1,818)

(2,090)

(2,345)

Profit after tax for the period

1,897,629

4,419,189

5,518,290

Other comprehensive income

Foreign exchange profit/(loss)

(182,115)

(33,779)

31,855

Total other comprehensive income/(loss)

(182,115)

(33,779)

31,855

Total comprehensive profit for the period

1,715,514

4,385,410

5,550,145

Earnings per share

6

Basic earnings per share

0.026

0.081

0.095

Diluted earnings per share

0.025

0.081

0.095

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

At 31 May 2020

Notes

As at 31

As at 31

As at 30

May 2020

May 2019

November 2019

Unaudited

Unaudited

Audited

US$

US$

US$

Assets

Non-current assets

Intangible assets

838,770

838,769

838,770

Financial assets at fair value through

7

22,758,873

18,577,365

20,335,925

profit and loss

Convertible Loan Notes

735,978

294,720

476,122

Property, plant and equipment

13,475

25,167

17,353

24,347,096

19,736,021

21,668,170

Current Assets

Trade and other receivables

1,038,395

410,770

815,866

Cash and cash equivalents

1,034,348

492,983

472,899

2,072,743

903,753

1,288,765

Total Assets

26,419,839

20,639,774

22,956,935

Liabilities

Current liabilities

Trade and other payables

127,635

114,124

310,160

Current income tax liabilities

500

500

500

Deferred Revenue

110,474

-

118,595

Total liabilities

238,609

114,624

429,255

Net Assets

26,181,230

20,525,150

22,527,680

Equity

Ordinary shares

8

494,861

326,036

372,984

Share premium

8

12,786,361

10,218,805

10,993,546

Retained earnings

12,976,794

9,940,614

11,055,821

Translation reserve

(4,617)

111,864

177,498

Merger reserve

(72,169)

(72,169)

(72,169)

Total Equity

26,181,230

20,525,150

22,527,680

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

For the six months ended 31 May 2020

Attributable to equity holders of the parent

Ordinary

Share

Translation

Merger

Retained

Total Equity

shares

Premium

Reserve

Reserve

Earnings

US$

US$

US$

US$

US$

US$

Unaudited

Balance at 1 December 2019

372,984

10,993,546

177,498

(72,169)

11,055,821

22,527,680

Share issue

121,877

1,967,235

2,089,112

Cost of share issue

(174,420)

(174,420)

Profit for the period

1,897,629

1,897,629

Other comprehensive income

(182,115)

(182,115)

Share based payments

23,346

23,345

Balance at 31 May 2020

494,861

12,786,361

(4,617)

(72,169)

12,976,794

26,181,231

Unaudited

Balance at 1 December 2018

326,036

10,218,805

145,643

(72,169)

5,516,655

16,134,970

Profit for the period

-

-

4,419,189

4,419,189

Other comprehensive income

-

-

(33,779)

(33,779)

Share based payments

-

-

4,770

4,770

Balance at 31 May 2019

326,036

10,218,805

111,864

(72,169)

9,940,614

20,525,150

Audited

Balance at 1 December 2018

326,036

10,218,805

145,643

(72,169)

5,516,655

16,134,970

Share issue

46,948

892,018

938,966

Cost of share issue

-

(117,277)

-

-

-

(117,277)

Profit for the period

-

-

-

-

5,518,290

5,518,290

Other comprehensive income

-

-

31,855

-

-

31,855

Share based payments

-

-

-

-

20,876

20,876

Balance at 30 November 2019

372,984

10,993,546

177,498

(72,169)

11,055,821

22,527,680

Share capital represents the amount subscribed for share capital at nominal value.

Share premium represents the amount subscribed for share capital in excess of nominal value and net of any directly attributable issue costs.

The merger reserve arose on the share for share exchange undertaken by the Company with Tekcapital Europe Limited on 18 February 2014.

CONSOLIDATED STATEMENT OF CASH FLOWS

For the six months ended 31 May 2020

Six months

Six months

For the year

ended

ended

ended

Group

Note

31 May 2020

31 May 2019

30 Nov 2019

US $

US $

US $

Cash flows from operating activities

Cash outflows from operations

(1,149,198)

(553,436)

(1,397,294)

Taxation paid

(1,818)

(2,090)

(2,345)

Net cash outflows from operating activities

(1,151,016)

(555,526)

(1,399,639)

Cash flows from investing activities

Purchase of financial assets at fair value

(219,584)

(109,643)

(111,810)

through profit and loss

Purchases of property, plant and equipment

(96)

(862)

Net cash outflows from investing activities

(219,584)

(109,739)

(112,672)

Cash flows from financing activities

Proceeds from issuance of ordinary shares

2,089,112

-

938,966

Costs of raising finance

(174,420)

-

(117,277)

Net cash inflows from financing activities

1,914,692

-

821,689

Net decrease in cash and cash equivalents

544,092

(665,266)

(690,622)

Cash and cash equivalents at beginning of

year

472,899

1,165,442

1,165,442

Exchange gain/(loss) on cash and cash

equivalents

17,357

(7,193)

(1,921)

Cash and cash equivalents at end of the

1,034,348

492,983

472,899

period

Notes to the financial information

  1. General information
    Tekcapital PLC is a company incorporated in England and Wales and domiciled in the UK. The address of the registered office is 12 New Fetter Lane, London, United Kingdom, EC4A 1JP. The Company is a public limited company, which is quoted on the AIM market of the London Stock Exchange in 2014.
    The principal accounting policies applied in the preparation of these consolidated financial statements are set out below. These policies have been consistently applied to all the periods presented, unless otherwise stated.
  2. Basis of preparation
    The financial information for the six months ended 31 May 2020 set out in this interim financial information is unaudited and does not constitute statutory financial statements. The interim condensed financial information has been presented in US Dollars ("$").
  3. Accounting policies

3.1 Statement of compliance

The accounting policies applied by the Group in these unaudited half year results are consistent with those applied in the annual financial statements for the year ended 30 November 2019.

The financial statements of Tekcapital PLC Group have been prepared in accordance with International Financial Reporting Standards (IFRS) and IFRS Interpretations Committee (IFRS IC) as adopted by the European Union and the Companies Act 2006 applicable to companies reporting under IFRS. The financial statements have been prepared under the historical cost convention.

The preparation of financial statements in conformity with IFRS requires the use of certain critical accounting estimates. It requires management to exercise its judgement in the process of applying the Group's accounting policies. The areas involving a higher degree of judgment or complexity, or areas where assumptions and estimates are significant to the consolidated financial statements are disclosed in note 4 of the FY 2019 accounts. The estimates that changed since then are disclosed in Note 7.

4. Going concern

The Group meets its day to day working capital requirements through its service offerings and monies raised in follow-on offerings. The Group's forecasts and projections indicate that the Group has sufficient cash reserves to operate within the level of its current facilities. If the group forecasts are not achieved the Directors are confident that additional funds could be raised through equity issues if required. After making enquiries, the Directors have a reasonable expectation that the Group has adequate resources to continue in operational existence for the foreseeable future.

The Company therefore continues to adopt the going concern basis in preparing both its consolidated financial statements and for its own financial statements.

5. Taxation

Immaterial charge of $1,818 has arisen in the six-month period ended 31 May 2020 (31 May 2019: $2,090).

6. Earnings per share

Basic earnings per share is calculated by dividing the earnings attributable to ordinary shareholders by the weighted average number of Ordinary Shares outstanding during the period.

Diluted earnings per share is calculated by dividing the earnings attributable to ordinary shareholders by the sum of weighted average number of (1) Ordinary Shares outstanding during the period and (2) Ordinary Shares to be issued assuming exercise of outstanding stock options with intrinsic value above $0 at 31 May 2020:

Six months ended

Six months ended

Year ended 30

31 May 2020

31 May 2019

November 2019

US$

US$

US$

Profit attributable

to equity

1,897,629

4,419,189

5,518,290

holders of the Company

Weighted average

number of

Ordinary Shares in issue:

Basic

72,332,693

54,353,042

58,010,322

Diluted

76,081,339

54,653,042

58,918,289

Basic profit (loss) per share ($)

0.026

0.081

0.095

Diluted profit (loss) per share ($)

0.025

0.081

0.095

7. Financial Assets at Fair Value through Profit or Loss

Group's investments in portfolio companies are listed below and classified as equity instruments. The principal place of business for portfolio companies listed below is England and Wales.

31 May

1 December

Additions

Exchange

Fair value

31 May

2019

difference

gain/(loss)

2020

2019

US $

US $

US $

US $

US $

US $

Guident Limited

12,656,321

15,526,195

(14,561)

15,511,631

Lucyd Ltd

1,394,811

1,129,022

2,301,979

3,431,001

Belluscura Limited

1,769,162

1,804,121

219,584

(84,053)

1,939,653

Salarius Ltd

2,689,345

1,833,426

1,833,426

Non Invasive Glucose

655

-

-

Tek Limited

Smart Food Tek

42,328

43,162

43,162

Limited

eSoma Limited

24,743

-

-

Total Balance

18,577,365

20,335,924

219,584

(98,614)

2,620,978

22,758,873

The valuation techniques used fall under, Level 2 - Observable techniques, other than quoted prices, and Level 3- Other techniques as defined by IFRS 13. There has been a transfer between Level 3 and Level 2 for Group's investment in Lucyd Ltd during the period. Fair value measurement hierarchy for financial assets as at 31 May 2020 with comparative amounts as of 30 November 2019:

Date of Valuation

Total

Significant

Significant

observable inputs

unobservable

(Level 2)

inputs (Level 3)

US $

US $

US $

Guident, Salarius

31 May 2020

17,388,219

17,388,219

Belluscura, Lucyd

31 May 2020

5,370,654

5,370,654

Total Balance

31 May 2020

22,758,873

5,370,654

17,388,219

Guident and others

30 November 2019

18,531,804

18,531,804

Belluscura Limited

30 November 2019

1,804,121

1,804,121

Total Balance

20,335,925

1,804,121

18,531,804

Guident (Nil Gain / Nil loss)

The total fair value remains unchanged from 30 November 2019 adjusted for adjusted for fluctuation of foreign exchange differences. The Group relied on the external valuation prepared by an independent patent valuation expert for Guident's IP portfolio performed as of 30 November 2019. Upon review of assumptions used in the 30 November 2019 valuation as well as business updates in H1 2020, the management noted no material events necessitating revisions. The management will obtain an update to the valuation report as of 30 November 2020.

Salarius (Nil Gain / Nil loss)

The total fair value remains unchanged from 30 November 2019. The Group relied on the external valuation prepared by an independent patent valuation expert for the Salarius' IP portfolio performed as of 30 November 2019. Upon review of assumptions used in the 30 November 2019 valuation as well as business updates in H1 2020, the management noted no material events necessitating revisions. The management will obtain an update to the valuation report as of 30 November 2020.

Lucyd Ltd ($2.3m gain)

On 1 July 2020, Innovative Eyewear, Inc, a fully owned subsidiary of Lucyd Ltd, commenced its Regulation Crowdfunding fundraise in the United States at US$3.75m pre-money valuation seeking approximately US$400K in funding for the further development and launch of its new Lucyd Lyte™ smart glasses and the Vyrb™ voice controlled, social media app. At the date of this report, the company has raised the minimum threshold required (US10k). Considering the occurrence of an observable input of multiple third parties (over 600 participants as of the date of this report) acquiring shares of the portfolio company at the US$3.75m pre-money valuation, reduced by the other components of Lucyd Ltd's Net Book Value of US$0.32m, the Group transferred the fair value of Lucyd Ltd from Level 3 as at 30 November 2019 to Level 2 as at 31 May 2020.

Belluscura ($0.1m gain)

The Group contributed $0.2m in a private placement held in May 2020 at 15 pence a share. The fair value of the holding increased by $0.1m as a result, adjusted for fluctuation of foreign exchange differences.

Other investments (Nil Gain / Nil loss)

Given early stage of commercialisation, fair value of remaining Smart Food TEK was recorded based on the cost of acquired IP, as their carrying amounts represent a reasonable approximation of fair value.

Under level 3 unobservable inputs. In the absence of observable inputs, the directors have considered the entities own data to determine the fair value, which equates to the original funds invested. They do not consider that any other available information would materially change or give a more reliable representation of the value.

This is the only category of financial instruments measured and re-measured at fair value.

8. Share Capital

The Company's ordinary shares are of £0.004 par value.

All of the Company's issued ordinary shares have full voting, dividend and capital distribution (including winding up) rights; they do not confer any rights of redemption. The Company does not hold any ordinary shares in treasury.

Issued and fully paid

Shares

Share capital

Share premium

Number

US$

US$

Ordinary shares of £0.004 each

At 1 December 2018

54,353,042

326,036

10,218,806

As at 31 May 2019

54,353,042

326,036

10,218,806

At 1 December 2018

54,353,042

326,036

10,218,806

Shares issued in further public

9,375,000

46,948

774,741

offering

As at 30 November 2019

63,728,042

372,984

10,993,546

Shares issued in further public

24,050,000

121,876

1,792,815

offering

As at 31 May 2020

87,778,042

494,860

12,786,361

  1. Related party transactions
    The Group has taken advantage of the exemption in IAS 24 "related parties" not to disclose transactions with other Group companies. During the period the Group did not employ any services of non-Group companies meeting the definition of related parties.
  2. Interim results
    The interim results for the six months ended 31 May 2020 will not be sent to shareholders but will be available from the Company's website at http://tekcapital.com/investors/.
    • Ends -

Disclaimer

Tekcapital plc published this content on 21 August 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 21 August 2020 04:21:17 UTC


share with twitter share with LinkedIn share with facebook
All news about TEKCAPITAL PLC
10/01TEKCAPITAL : Option Exercise
PU
09/28PORTFOLIO COMPANY UPDATE : Lucyd
PU
09/24PORTFOLIO COMPANY UPDATE : Salarius
PU
09/21PORTFOLIO COMPANY UPDATE : Guident
PU
09/14PORTFOLIO COMPANY UPDATE : Guident
PU
08/21TEKCAPITAL : Unaudited Interim Results
PU
07/27TEKCAPITAL : Results of AGM
PU
07/13TEKCAPITAL : Conference Call
PU
06/16PORTFOLIO COMPANY UPDATE : Guident Ltd.
PU
05/19TEKCAPITAL : General Meeting & Completion of Fundraise
PU
More news
Financials
Sales 2019 7,72 M - -
Net income 2019 5,52 M - -
Net cash 2019 0,47 M - -
P/E ratio 2019 0,57x
Yield 2019 -
Capitalization 12,6 M 12,6 M -
EV / Sales 2018 0,36x
EV / Sales 2019 0,51x
Nbr of Employees 6
Free-Float 70,1%
Chart TEKCAPITAL PLC
Duration : Period :
Tekcapital plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TEKCAPITAL PLC
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Average target price
Last Close Price 0,11 
Spread / Highest target -
Spread / Average Target -
Spread / Lowest Target -
Managers
NameTitle
Clifford M. Gross Chairman & Chief Executive Officer
Konrad Dabrowski Chief Financial Officer
Selwyn Lloyd Chief Information Officer
Robert Clell Miller Non-Executive Director
Louis Emmanuel Castro Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
TEKCAPITAL PLC109.52%13
ACCENTURE PLC9.41%146 573
TATA CONSULTANCY SERVICES26.71%139 856
INTERNATIONAL BUSINESS MACHINES CORPORATION-12.44%104 527
INFOSYS LIMITED55.58%65 654
AUTOMATIC DATA PROCESSING, INC.-14.01%63 024